1. Home
  2. DLPN vs RGNT Comparison

DLPN vs RGNT Comparison

Compare DLPN & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.72

Market Cap

20.6M

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.90

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLPN
RGNT
Founded
1996
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
20.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
DLPN
RGNT
Price
$1.72
$3.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.2K
9.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.81
N/A
EPS
N/A
N/A
Revenue
$51,684,984.00
N/A
Revenue This Year
$10.62
N/A
Revenue Next Year
$13.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.85
N/A
52 Week Low
$0.75
$3.70
52 Week High
$1.88
$8.35

Technical Indicators

Market Signals
Indicator
DLPN
RGNT
Relative Strength Index (RSI) 61.33 33.26
Support Level $1.46 N/A
Resistance Level $1.73 $7.25
Average True Range (ATR) 0.09 0.42
MACD 0.02 -0.03
Stochastic Oscillator 94.64 19.47

Price Performance

Historical Comparison
DLPN
RGNT

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: